Johannes Scheid wins 2012 Weintraub Graduate Student Award

Scheid is one of 13 awardees, all advanced graduate students at or near the completion of their studies in the biological sciences and chosen for the quality, originality and significance of their thesis research.
More »

Tags: ,

Elaine Fuchs to receive 2012 March of Dimes Prize in Developmental Biology

The award recognizes Fuchs’s contributions to our understanding of skin biology and skin stem cells, including discoveries that have led to advancements in treating skin cancer and severe burns.

More »

Tags:

Tarun Kapoor to receive Irving Sigal Young Investigator Award

The award recognizes Dr. Kapoor’s work combining chemical and biological approaches to dissect mechanisms of cell division. and will be presented at The Protein Society’s annual symposium in August.
More »

$15 million gift from Helmsley Trust to fund research on digestive diseases

Funds will establish a new center, to be known as the Center for Basic and Translational Research on Disorders of the Digestive System, which will support interdisciplinary basic research and foster collaborations among some 20 Rockefeller labs that study biological processes related to the digestive system. More »

Norton Zinder, pioneering molecular geneticist, dies at 83

Zinder was a geneticist and microbiologist whose research on the genetics of bacteria and on the properties of bacteriophages provided important information on the mechanisms of heredity. He died February 3 after a long illness. More »

Tags: , ,

Study in fruit flies reveals a gene affecting the ability to sleep

Research suggests that a newly identified gene known as insomniac is an important reason why we get drowsy and fall asleep. By cloning and testing this gene in fruit flies, Rockefeller University researchers say they have discovered an entirely new mechanism by which sleep is regulated. More »

Tags:

In cancer, molecular signals that recruit blood vessels also trigger metastasis

Cancer cells are most deadly when they’re on the move – able not only to destroy whatever organ they are first formed in, but also to create colonies elsewhere in the body. New research has now shown how a small RNA prevents the recruitment and formation of blood vessels near cancer cells destined to become metastases, a process that must occur in order for them to grow. The scientists say that if drugs could be developed that act on the pathways regulated by this microRNA, they might be able to block the metastatic process and prevent some breast cancers from becoming deadly. More »

Tags: , ,

2011 Nobel Prize Ceremony to be webcast live

Tomorrow, the family of Nobel Prize winner Ralph M. Steinman, who died September 30, will accept the Nobel medal and diploma on his behalf from King Carl XVI Gustaf of Sweden. The ceremony will be Webcast live beginning at 10:20 a.m. Eastern Time. A video of the Nobel Prize Award Ceremony will also be available a few days later. More »

Tags: , ,

Resident protection

To keep the body safe, the immune system enlists more than one form of protection. Rockefeller University scientists, working in collaboration with researchers at New York University, are learning about an important, but little-known, network of dendritic cells in lymph nodes through innovative, live-action imaging. More »

Tags: , ,

Statin-intolerant patients need a different type of clinical trial, Rockefeller researchers say

Although only five percent of people in clinical trials report side effects from statin drugs, in practice the problem is far greater. Clinical trials need to better address the needs of statin-intolerant patients, Rockefeller researchers say. More »

University joins 10 leading medical and research institutions to form New York Genome Center

The New York Genome Center, which will become one of the largest genomic facilities in North America, will begin operations as early as spring 2012 in its 120,000 square foot Manhattan facility.
More »

Marc Tessier-Lavigne elected to Institute of Medicine

A world leader in the study of brain development, Tessier-Lavigne has pioneered the identification of the molecules that direct the formation of connections among nerve cells to establish neuronal circuits in the mammalian brain and spinal cord. Tessier-Lavigne is among 65 new members and five foreign associates elected to the Institute this year. More »

Tags: ,

Neurobiologist visits Rockefeller as part of renewed scientific exchange program with Karolinska Institute

Thomas Perlmann, a neurobiologist at the Karolinska Institute who studies the dopamine-producing cells that die during the development of Parkinson’s disease, will visit the Rockefeller University campus this week and give the Nicholson Lecture on Friday. The lecture is part of a recently renewed program that supports research exchanges between the university and the Karolinska Institute. More »

Michael W. Young to receive 2011 Horwitz Prize for studies on molecular basis of circadian rhythms

Michael W. Young will share Columbia University’s Louisa Gross Horwitz Prize with with Jeffrey C. Hall and Michael Rosbash for their work on the molecular basis of circadian rhythms. His research provides a basis for the development of possible treatments for hereditary sleep disorders in humans. More »

Rockefeller University scientist Ralph Steinman, honored today with Nobel Prize for discovery of dendritic cells, dies at 68

Rockefeller University cell biologist Ralph M. Steinman, who discovered the immune system’s sentinel dendritic cells and demonstrated that science can fruitfully harness the power of these cells and other components of the immune system to curb infections and other communicable diseases, is this year’s recipient of the Nobel Prize in Physiology or Medicine, the Nobel Foundation in Stockholm, Sweden, announced today. He shares half the prize with Bruce A. Beutler and Jules A. Hoffmann. More »

Tags: ,

Papavasiliou and Stavropoulos receive “transformative” NIH grant

Rockefeller University’s Nina Papavasiliou will receive a grant from the National Institutes of Health under a program designed to encourage high-risk, high impact research. The grant will fund efforts to develop new ways of engineering therapeutic antibodies that could lead to novel vaccines for a number of communicable diseases ranging from HIV to flu as well as non-communicable diseases, such as various cancers, neurodegenerative diseases and drug addiction. More »

Gaby Maimon named one of Popular Science’s “Brilliant Ten”

The honor recognizes Maimon’s development of a technique to monitor electrical activity in individual neurons as fruit flies navigate a virtual world in “tethered flight.” Maimon’s platform provides a bridge to link genes, through the electrical activity of neurons, to fly behavior. In his system, flies are attached to a small plate where they can flap their wings in “tethered flight.” More »

Rockefeller University receives $36.1 million to help translate science into cures

Rockefeller University’s Center for Clinical and Translational Science (CCTS), a center aimed at accelerating the pace of translating science into real-life solutions for patients, has received $36.1 million from the National Institutes of Health to expand its work over the next five years. The CCTS is among 10 institutes nationwide to receive the renewed funding, in recognition of their successes during the first five years of the NIH’s Clinical and Translational Science Awards program. More »

Tags: , ,

DNA testing by high school students shows many teas contain unlisted ingredients

Unlisted ingredients identified by DNA barcoding technology include weeds such as annual bluegrass and herbal plants such as chamomile. Though mostly harmless, the surprise ingredients could affect a tiny minority of consumers with acute allergies. More »

Tags: , , ,

Scientists identify broad and potent HIV antibodies that mimic CD4 binding

A new approach gives researchers the ability to isolate single antibodies as well as investigate entire families of highly active antibodies against HIV.
More »

Tags: , , ,